Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1
- PMID: 11423572
- DOI: 10.1681/ASN.V1271434
Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1
Abstract
Few studies have examined the role of the microvasculature in progressive renal disease. It was hypothesized that impaired angiogenesis might occur in the diseased kidney and could contribute to renal scarring. Progressive renal disease was induced in rats by 5/6 renal ablation and those rats were compared with sham-operated control animals at multiple time points, for examination of changes in the microvasculature and the expression of angiogenic factors. An early angiogenic response was documented in remnant kidneys, with increases in the proliferation of peritubular (1 wk) and glomerular (2 wk) endothelial cells. Subsequently, however, there was a decrease in endothelial cell proliferation, which was reduced to levels below those of sham-treated animals, in conjunction with interstitial expression of the antiangiogenic factor thrombospondin-1 (TSP-1) and decreased tubular expression of the proangiogenic factor vascular endothelial growth factor (VEGF). Both the increase in TSP-1 expression and the loss of VEGF expression were correlated with capillary loss and the development of glomerulosclerosis and interstitial fibrosis. Progressive macrophage infiltration was correlated both spatially and quantitatively with the sites of absent or diminished VEGF expression. In addition, macrophage-associated cytokines (interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha) inhibited VEGF mRNA expression and protein secretion by cultured tubular epithelial cells of the medullary thick ascending limb, under both normoxic and hypoxic conditions. Impaired angiogenesis characterizes the remnant kidney model and is correlated with progression. The impaired angiogenesis may be mediated by alterations in the renal expression of TSP-1 and VEGF, with the latter being regulated by macrophage-associated cytokines.
Similar articles
-
Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease.Am J Kidney Dis. 2001 Mar;37(3):601-11. doi: 10.1053/ajkd.2001.22087. Am J Kidney Dis. 2001. PMID: 11228186
-
Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function.J Am Soc Nephrol. 2001 Jul;12(7):1448-1457. doi: 10.1681/ASN.V1271448. J Am Soc Nephrol. 2001. PMID: 11423573
-
Nitric oxide modulates vascular disease in the remnant kidney model.Am J Pathol. 2002 Jul;161(1):239-48. doi: 10.1016/S0002-9440(10)64175-2. Am J Pathol. 2002. PMID: 12107108 Free PMC article.
-
Vascular endothelial growth factor: a new player in the pathogenesis of renal fibrosis.Curr Opin Nephrol Hypertens. 2003 Jan;12(1):43-9. doi: 10.1097/00041552-200301000-00008. Curr Opin Nephrol Hypertens. 2003. PMID: 12496665 Review.
-
Kidney vasculogenesis and angiogenesis: role of vascular endothelial growth factor.Eur Rev Med Pharmacol Sci. 1999 Jul-Aug;3(4):149-53. Eur Rev Med Pharmacol Sci. 1999. PMID: 11073120 Review.
Cited by
-
Therapeutic effects of human amniotic fluid-derived stem cells on renal interstitial fibrosis in a murine model of unilateral ureteral obstruction.PLoS One. 2013 May 28;8(5):e65042. doi: 10.1371/journal.pone.0065042. Print 2013. PLoS One. 2013. PMID: 23724119 Free PMC article.
-
Intravascular Delivery of Biologics to the Rat Kidney.J Vis Exp. 2016 Sep 1;(115):54418. doi: 10.3791/54418. J Vis Exp. 2016. PMID: 27685329 Free PMC article.
-
Implications of treatment that target protective mechanisms against diabetic nephropathy.Semin Nephrol. 2012 Sep;32(5):471-8. doi: 10.1016/j.semnephrol.2012.07.010. Semin Nephrol. 2012. PMID: 23062988 Free PMC article. Review.
-
Hypoxia in renal disease with proteinuria and/or glomerular hypertension.Am J Pathol. 2004 Dec;165(6):1979-92. doi: 10.1016/S0002-9440(10)63249-X. Am J Pathol. 2004. PMID: 15579441 Free PMC article.
-
Current understanding of the administration of mesenchymal stem cells in acute kidney injury to chronic kidney disease transition: a review with a focus on preclinical models.Stem Cell Res Ther. 2019 Dec 16;10(1):385. doi: 10.1186/s13287-019-1507-3. Stem Cell Res Ther. 2019. PMID: 31843011 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous